tradingkey.logo

NRX Pharmaceuticals Inc

NRXP
2.370USD
+0.190+8.72%
Close 12/19, 16:00ETQuotes delayed by 15 min
65.61MMarket Cap
LossP/E TTM

NRX Pharmaceuticals Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.36
40.70%
Analyst Rating
BUY
2025-12-09

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.360, with a year-on-year change of 40.70%.

What is the net income of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its net income was -25.13M, with a year-on-year change of 16.69%.

What is the net margin of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 180.14%, with a year-on-year change of 43.84%.

What is the Return on Equity (ROE) of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.

What is the Return on Assets (ROA) of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -458.25%, with a year-on-year change of -151.78%.

What is the operating profit of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -19.70M, with a year-on-year change of 28.58%.

What are the current assets of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its current assets were 3.30M, with a year-on-year change of -52.03%.

What are the total assets of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its total assets of NRX Pharmaceuticals Inc were 3.65M, with a year-on-year change of -50.09%.

What are the total liabilities of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of NRX Pharmaceuticals Inc were 26.87M, with a year-on-year change of 41.09%.

What is the total equity of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its total equity of NRX Pharmaceuticals Inc was -23.22M, with a year-on-year change of -97.93%.

What is the net operating income of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its net operating income of NRX Pharmaceuticals Inc was -25.13M, with a year-on-year change of 16.66%.

What is the net investment of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its net investment of NRX Pharmaceuticals Inc was --, with a year-on-year change of 100.00%.

What is the net financing of NRX Pharmaceuticals Inc?

According to NRX Pharmaceuticals Inc's FY2024 earnings report, its net financing of NRX Pharmaceuticals Inc was 7.49M, with a year-on-year change of 20.71%.
KeyAI